Tsonis Anastasios 4/A
4/A · RESPONSE BIOMEDICAL CORP · Filed Jun 21, 2012
Insider Transaction Report
Form 4/AAmended
Tsonis Anastasios
Controller
Transactions
- Award
Stock Option (Right to Buy)
2012-04-02+322,500→ 322,500 totalExercise: $0.11Exp: 2022-04-02→ Common Stock (322,500 underlying)
Footnotes (4)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]25% of the options shall vest and become exercisable on the date which is one year after the date of grant.
- [F3]An additional 1/48th of the options initially granted will vest and be exercisable on the first day of each calendar month beginning on the first calendar month after the calendar month in which the options described in preceding footnote (2) vest and continuing for 35 additional consecutive calendar months until all such options are vested and fully exercisable.
- [F4]The options granted were subject to approval of shareholders and the Toronto Stock Exchange. Shareholders approval was obtained on June 19, 2012.